What’s ahead?
Don’t forget to attend this afternoon’s Future of Dermatology Symposium to learn about new and promising innovations.
F001 – Future of Dermatology Symposium: The New Skin Frontier: Innovation at the Intersection of Biopharma and Academia
1–5 p.m. | Thursday, July 10
Grand Hall J
Your guide to what’s coming soon in dermatology is just hours away. Today’s session, F001 – Future of Dermatology Symposium: The New Skin Frontier: Innovation at the Intersection of Biopharma and Academia, will provide a comprehensive look at innovation, research, and promising solutions to better serve dermatologists and patients.
The session will spotlight the concept of problem-based innovation and the process of seeking solutions through commercialization. Co-session directors include Lilit Garibyan, MD, PhD, FAAD; Kenneth B. Gordon, MD, FAAD; Joseph C. Kvedar, MD, FAAD; Bobby Y. Reddy, MD; Hensin Tsao, MD, PhD, FAAD; and Sandy Sharon Tsao, MD, FAAD.
“The future of dermatology lies in collaboration, where academia meets industry, where clinicians identify unmet clinical needs and partner with researchers and engineers, who have the tools and expertise to develop and test new solutions, and where industry plays a vital role in supporting and commercializing innovations born in academia,” said Dr. Garibyan, associate professor of dermatology at Harvard Medical School in Boston.
Lilit Garibyan, MD, PhD, FAAD
This year’s symposium will focus on the dynamic intersection of biopharma and academia, featuring the latest advancements in dermatologic research and technology. Discussions include the potential of new therapies, emerging trends, and insights into how collaboration between industry and academia is paving the way for the next generation of dermatologic treatments. Panelists will review a range of selected abstracts representing therapeutics, cosmetics, molecular technologies, artificial intelligence, telemedicine, and mobile and imaging technologies.
“We’re seeing dermatology leap from being a specialty focused solely on the skin to one that touches the entire body,” Dr. Garibyan said. “As clinicians, we witness the unmet needs in health care every day. The status quo is no longer enough. Innovation, driven by clinical insight and supported by industry, is the only path forward. Together, we share a responsibility to bring bold, evidence-based solutions to our patients.”
